MAY 16, 2020 11:07 AM PDT

Stem Cell Method (Parkinson's) Could Avoid Transplant Rejection

WRITTEN BY: Amanda Mikyska

Jeffery Schweitzer, MD, PhD and lead author of the study elaborates on the research methods and hopes for stem cell technology in the future. 

 

Researchers at McLean Hospital and Massachusetts General Hospital (MGH) have tested a stem cell treatment method that avoids rejection by the patient's body, a significant limitation of stem cell therapy.  The experiment was only conducted in one Parkinson's patient, but researchers hope the results will open the door for a larger sample size.  

Stem cells have not "differentiated," meaning they have not taken the form of a specific cell type, such as a skin cell or a nerve cell.  Stem cells give rise to other undefined cells, which either become stem cells or differentiate.  Over the past decade, the technology to use stem cells as personalized therapy has evolved rapidly.  For example, in Multiple Sclerosis (MS) research, the hope is to swap out immune cells that are attacking the patient's own neurons with immune cells, grown from stem cells, that will not attack the neurons.  

On May 13, 2020, MGH released the study taking stem cells from one patient's skin to replace his own dopaminergic neurons lost during his Parkinson's progression.  Dopaminergic neurons produce the majority of the body's dopamine. Parkinson's is associated with tremor and a decline in fine motor skills because the nerve cells do not have enough dopamine to transmit signals between the muscles and the brain.  This study differs from other stem cell research because stem cells typically originate from a bank of stem cells, not the patient's own body.  Though cell banks have greater control over what characteristics the cells have, the patient's body often rejects the transplant.

So far, the 69-year-old patient has responded well to the stem cell transplant.  His body accepted the stem cells, which have reproduced and matured into dopaminergic neurons. Researchers associated with the study say the results are encouraging but emphasize that it was only a single patient test.

The National Institute of Health, McLean Hospital, and MGH, primarily funded the study, but the patient at the center of the study also contributed to the funding.  The researchers worked with the MGH Institutional Review Board to clear all ethical hurdles. 

 

Sources: Schweitzer et. al., ScienceDaily, Mayo Clinic, Harvard Stem Cell Institute

About the Author
  • Amanda graduated for the University of Massachusetts Boston with a degree in Biology. After working in research on creating biochemicals from genetically engineered yeast, she started freelance science writing while traveling the world. She writes about the latest research in Neuroscience, Genetics & Genomics, and Immunology. Interested in working on solutions for food/water security, sustainable fuel, and sustainable farming. Amanda is an avid skier, podcast listener, and has run two triathlons.
You May Also Like
FEB 12, 2020
Neuroscience
FEB 12, 2020
How AI and Neuroscience Propel Each Other Forward
Traditional notions of artificial intelligence (AI) are outdated. Rather than simply being able to understand inventory ...
MAR 01, 2020
Genetics & Genomics
MAR 01, 2020
Treating Huntington's Disease With a Gene Therapy That Targets Brain Cells
A new therapeutic approach for Huntington's disease may aid patients with other neurodegenerative disorders.
MAR 01, 2020
Cardiology
MAR 01, 2020
Vegetarian Diet May Reduce Stroke Risk
Stroke is the world’s second leading cause of death. Now, researchers from Tzu Chi University in Hualien, Taiwan h ...
MAR 08, 2020
Neuroscience
MAR 08, 2020
Brain Scans Reveal There are Two Kinds of Schizophrenia
Schizophrenia is a chronic neurological disorder that affects around 3.5 million people in the US; three quarters of the ...
MAR 13, 2020
Technology
MAR 13, 2020
Advancing Brain-Machine Interfaces
At Stanford University, researchers have designed a device that connects the brain to silicon-based technologies. Althou ...
MAY 04, 2020
Cannabis Sciences
MAY 04, 2020
Can Cannabis Improve Chronic Insomnia?
Around 30% of Americans have insomnia. A serious problem, researchers have found that cannabis products may be able to h ...
Loading Comments...